...Good evening and welcome to the webcast of OSE Immunotherapeutics. This evening we're going to talk about the strategic plan that we announced yesterday. My name is Fiona Olivier. I'm Chief Corporate Affairs and Investor Relations Officer at OSE, and it's my pleasure to have Mark Le Bozec, our CEO, and Thomas Gidoin, who's our CFO. (Operator Instructions). I'm going to start off with you, Marc. You are the CEO and you've been so for only two months. First, you were elected to the Board of Directors at the shareholder meeting on the September 30, and then--two days later, you were appointed CEOO. What have you been doing since then? Marc Le Bozec ...
